202 related articles for article (PubMed ID: 21212274)
1. TAp73 induction by nitric oxide: regulation by checkpoint kinase 1 (CHK1) and protection against apoptosis.
Tebbi A; Guittet O; Cottet MH; Vesin MF; Lepoivre M
J Biol Chem; 2011 Mar; 286(10):7873-7884. PubMed ID: 21212274
[TBL] [Abstract][Full Text] [Related]
2. Stalled replication induces p53 accumulation through distinct mechanisms from DNA damage checkpoint pathways.
Ho CC; Siu WY; Lau A; Chan WM; Arooz T; Poon RY
Cancer Res; 2006 Feb; 66(4):2233-41. PubMed ID: 16489026
[TBL] [Abstract][Full Text] [Related]
3. p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2.
Urist M; Tanaka T; Poyurovsky MV; Prives C
Genes Dev; 2004 Dec; 18(24):3041-54. PubMed ID: 15601819
[TBL] [Abstract][Full Text] [Related]
4. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
Liu JH; Liu CC; Yen CC; Gau JP; Wang WS; Tzeng CH
Int J Cancer; 2009 Jul; 125(1):71-7. PubMed ID: 19291793
[TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase.
Yoda A; Toyoshima K; Watanabe Y; Onishi N; Hazaka Y; Tsukuda Y; Tsukada J; Kondo T; Tanaka Y; Minami Y
J Biol Chem; 2008 Jul; 283(27):18969-79. PubMed ID: 18482988
[TBL] [Abstract][Full Text] [Related]
6. Runt-related transcription factor 2 attenuates the transcriptional activity as well as DNA damage-mediated induction of pro-apoptotic TAp73 to regulate chemosensitivity.
Ozaki T; Sugimoto H; Nakamura M; Hiraoka K; Yoda H; Sang M; Fujiwara K; Nagase H
FEBS J; 2015 Jan; 282(1):114-28. PubMed ID: 25331851
[TBL] [Abstract][Full Text] [Related]
7. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
[TBL] [Abstract][Full Text] [Related]
8. Chk1 is essential for tumor cell viability following activation of the replication checkpoint.
Cho SH; Toouli CD; Fujii GH; Crain C; Parry D
Cell Cycle; 2005 Jan; 4(1):131-9. PubMed ID: 15539958
[TBL] [Abstract][Full Text] [Related]
9. Dual regulation of Cdc25A by Chk1 and p53-ATF3 in DNA replication checkpoint control.
Demidova AR; Aau MY; Zhuang L; Yu Q
J Biol Chem; 2009 Feb; 284(7):4132-9. PubMed ID: 19060337
[TBL] [Abstract][Full Text] [Related]
10. Comparison of checkpoint responses triggered by DNA polymerase inhibition versus DNA damaging agents.
Liu JS; Kuo SR; Melendy T
Mutat Res; 2003 Nov; 532(1-2):215-26. PubMed ID: 14643438
[TBL] [Abstract][Full Text] [Related]
11. p73alpha regulation by Chk1 in response to DNA damage.
Gonzalez S; Prives C; Cordon-Cardo C
Mol Cell Biol; 2003 Nov; 23(22):8161-71. PubMed ID: 14585975
[TBL] [Abstract][Full Text] [Related]
12. Gain of cellular adaptation due to prolonged p53 impairment leads to functional switchover from p53 to p73 during DNA damage in acute myeloid leukemia cells.
Chakraborty J; Banerjee S; Ray P; Hossain DMS; Bhattacharyya S; Adhikary A; Chattopadhyay S; Das T; Sa G
J Biol Chem; 2010 Oct; 285(43):33104-33112. PubMed ID: 20675383
[TBL] [Abstract][Full Text] [Related]
13. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis.
Pabla N; Huang S; Mi QS; Daniel R; Dong Z
J Biol Chem; 2008 Mar; 283(10):6572-83. PubMed ID: 18162465
[TBL] [Abstract][Full Text] [Related]
14. PLK2 phosphorylates and inhibits enriched TAp73 in human osteosarcoma cells.
Hu ZB; Liao XH; Xu ZY; Yang X; Dong C; Jin AM; Lu H
Cancer Med; 2016 Jan; 5(1):74-87. PubMed ID: 26625870
[TBL] [Abstract][Full Text] [Related]
15. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of p73 variants in response to cisplatin treatment in SH-SY5Y neuroblastoma cells.
Million K; Horvilleur E; Goldschneider D; Agina M; Raguénez G; Tournier F; Bénard J; Douc-Rasy S
Int J Oncol; 2006 Jul; 29(1):147-54. PubMed ID: 16773194
[TBL] [Abstract][Full Text] [Related]
17. TAp73-mediated the activation of c-Jun N-terminal kinase enhances cellular chemosensitivity to cisplatin in ovarian cancer cells.
Zhang P; Liu SS; Ngan HY
PLoS One; 2012; 7(8):e42985. PubMed ID: 22900074
[TBL] [Abstract][Full Text] [Related]
18. ATR and Chk1 suppress a caspase-3-dependent apoptotic response following DNA replication stress.
Myers K; Gagou ME; Zuazua-Villar P; Rodriguez R; Meuth M
PLoS Genet; 2009 Jan; 5(1):e1000324. PubMed ID: 19119425
[TBL] [Abstract][Full Text] [Related]
19. Induction of p21 and nuclear accumulation of TAp73alpha and c-abl during apoptosis of cisplatin-treated primary pancreatic acinar cells.
Sphyris N; Morris RG; Harrison DJ
Int J Oncol; 2004 Dec; 25(6):1661-70. PubMed ID: 15547703
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic death induced by the cyclophosphamide analogue mafosfamide in human lymphoblastoid cells: contribution of DNA replication, transcription inhibition and Chk/p53 signaling.
Goldstein M; Roos WP; Kaina B
Toxicol Appl Pharmacol; 2008 May; 229(1):20-32. PubMed ID: 18289623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
